Why the study?
Increasing oral anticoagulant use imposes rising healthcare costs, making patient self-management via electronic health software a potential strategy to systematize and improve care quality.
Does self-management using electronic health software improve therapeutic outcomes and reduce complications in patients on vitamin K antagonist therapy?
Does self-management using electronic health software improve therapeutic outcomes and reduce complications in patients on vitamin K antagonist therapy?
The use of electronic health software for self-management of vitamin K antagonist therapy improves time in therapeutic range and patient satisfaction without increasing major complications.
Answers are grounded in this paper and cite their sources.
Supports shifting VKA management to software-enabled self-care; extends evidence for digital tools in chronic anticoagulation.
Introduction and Aim: Currently, between one to two percent of the population of highincome countries is being treated with oral anticoagulants. This trend will continue to increase due to the sedentary lifestyle and its complications, in particular the increasing prevalence of cardiovascular disease. Importantly, this increasing trend will impose additional costs on health systems. An appropriate strategy to respond to this ever-increasing demand and cost management is to transfer all or part of the treatment management process to patients. In this regard, the use of information technology, in particular electronic health software, can be an appropriate method for facilitating, systematising and improving the quality of self-management of vitamin K antagonist therapy. In this systematic review, studies that examined the results of using electronic health software in the self-management of oral anticoagulation therapy were reviewed.
No takes yet. Share an insight, caveat, or question.
Hamid Moghaddasi (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: